Global Non-alcoholic Steatohepatitis Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 139716
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 123
  • list Pharmaceuticals and Healthcare

Non-alcoholic steatohepatitis (NASH), is a common liver disease, often called as silent liver disease. It is asymptomatic until its later stages, and thus many patients are unaware of their condition.

Scope of the Report:

This report studies the Non-alcoholic Steatohepatitis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Non-alcoholic Steatohepatitis market by product type and applications/end industries.

NASH is projected to lead the cause of liver transplantation in the U.S. in the coming years. Some major factors such as higher prevalence of NASH, expected launch of pipeline drugs, and higher number of unmet needs drive the growth of this market. However, poor diagnosis of NASH due to the lack of ideal diagnostic technologies limit the growth of the NASH market.

The global Non-alcoholic Steatohepatitis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Non-alcoholic Steatohepatitis.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

GENFIT

Gilead Sciences (GILD)

AstraZeneca

Novartis

Bristol-Myers Squibb Company

Allergan

Novo Nordisk

Boehringer Ingelheim

Pfizer

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Serum biomarkers

Hepatic fibrosis biomarkers

Apoptosis biomarkers

Oxidative stress biomarkers

Others

Market Segment by Applications, can be divided into

Pharma & CRO Industry

Hospitals

Diagnostic Labs

Academic Research Institutes

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Non-alcoholic Steatohepatitis Market Overview

1.1 Product Overview and Scope of Non-alcoholic Steatohepatitis

1.2 Classification of Non-alcoholic Steatohepatitis by Types

1.2.1 Global Non-alcoholic Steatohepatitis Revenue Comparison by Types (2017-2023)

1.2.2 Global Non-alcoholic Steatohepatitis Revenue Market Share by Types in 2017

1.2.3 Serum biomarkers

1.2.4 Hepatic fibrosis biomarkers

1.2.5 Apoptosis biomarkers

1.2.6 Oxidative stress biomarkers

1.2.7 Others

1.3 Global Non-alcoholic Steatohepatitis Market by Application

1.3.1 Global Non-alcoholic Steatohepatitis Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Pharma & CRO Industry

1.3.3 Hospitals

1.3.4 Diagnostic Labs

1.3.5 Academic Research Institutes

1.4 Global Non-alcoholic Steatohepatitis Market by Regions

1.4.1 Global Non-alcoholic Steatohepatitis Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Non-alcoholic Steatohepatitis Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Non-alcoholic Steatohepatitis Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-alcoholic Steatohepatitis Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Non-alcoholic Steatohepatitis Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-alcoholic Steatohepatitis Status and Prospect (2013-2023)

1.5 Global Market Size of Non-alcoholic Steatohepatitis (2013-2023)

2 Manufacturers Profiles

2.1 GENFIT

2.1.1 Business Overview

2.1.2 Non-alcoholic Steatohepatitis Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 GENFIT Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2016-2017)

2.2 Gilead Sciences (GILD)

2.2.1 Business Overview

2.2.2 Non-alcoholic Steatohepatitis Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Gilead Sciences (GILD) Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2016-2017)

2.3 AstraZeneca

2.3.1 Business Overview

2.3.2 Non-alcoholic Steatohepatitis Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 AstraZeneca Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2016-2017)

2.4 Novartis

2.4.1 Business Overview

2.4.2 Non-alcoholic Steatohepatitis Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Novartis Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2016-2017)

2.5 Bristol-Myers Squibb Company

2.5.1 Business Overview

2.5.2 Non-alcoholic Steatohepatitis Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Bristol-Myers Squibb Company Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2016-2017)

2.6 Allergan

2.6.1 Business Overview

2.6.2 Non-alcoholic Steatohepatitis Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Allergan Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2016-2017)

2.7 Novo Nordisk

2.7.1 Business Overview

2.7.2 Non-alcoholic Steatohepatitis Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Novo Nordisk Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2016-2017)

2.8 Boehringer Ingelheim

2.8.1 Business Overview

2.8.2 Non-alcoholic Steatohepatitis Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Boehringer Ingelheim Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2016-2017)

2.9 Pfizer

2.9.1 Business Overview

2.9.2 Non-alcoholic Steatohepatitis Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Pfizer Non-alcoholic Steatohepatitis Revenue, Gross Margin and Market Share (2016-2017)

3 Global Non-alcoholic Steatohepatitis Market Competition, by Players

3.1 Global Non-alcoholic Steatohepatitis Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Non-alcoholic Steatohepatitis Players Market Share

3.2.2 Top 10 Non-alcoholic Steatohepatitis Players Market Share

3.3 Market Competition Trend

4 Global Non-alcoholic Steatohepatitis Market Size by Regions

4.1 Global Non-alcoholic Steatohepatitis Revenue and Market Share by Regions

4.2 North America Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

4.3 Europe Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

4.5 South America Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

5 North America Non-alcoholic Steatohepatitis Revenue by Countries

5.1 North America Non-alcoholic Steatohepatitis Revenue by Countries (2013-2018)

5.2 USA Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

5.3 Canada Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

5.4 Mexico Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

6 Europe Non-alcoholic Steatohepatitis Revenue by Countries

6.1 Europe Non-alcoholic Steatohepatitis Revenue by Countries (2013-2018)

6.2 Germany Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

6.3 UK Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

6.4 France Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

6.5 Russia Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

6.6 Italy Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Non-alcoholic Steatohepatitis Revenue by Countries

7.1 Asia-Pacific Non-alcoholic Steatohepatitis Revenue by Countries (2013-2018)

7.2 China Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

7.3 Japan Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

7.4 Korea Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

7.5 India Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

8 South America Non-alcoholic Steatohepatitis Revenue by Countries

8.1 South America Non-alcoholic Steatohepatitis Revenue by Countries (2013-2018)

8.2 Brazil Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

8.3 Argentina Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

8.4 Colombia Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Non-alcoholic Steatohepatitis by Countries

9.1 Middle East and Africa Non-alcoholic Steatohepatitis Revenue by Countries (2013-2018)

9.2 Saudi Arabia Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

9.3 UAE Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

9.4 Egypt Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

9.5 Nigeria Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

9.6 South Africa Non-alcoholic Steatohepatitis Revenue and Growth Rate (2013-2018)

10 Global Non-alcoholic Steatohepatitis Market Segment by Type

10.1 Global Non-alcoholic Steatohepatitis Revenue and Market Share by Type (2013-2018)

10.2 Global Non-alcoholic Steatohepatitis Market Forecast by Type (2018-2023)

10.3 Serum biomarkers Revenue Growth Rate (2013-2023)

10.4 Hepatic fibrosis biomarkers Revenue Growth Rate (2013-2023)

10.5 Apoptosis biomarkers Revenue Growth Rate (2013-2023)

10.6 Oxidative stress biomarkers Revenue Growth Rate (2013-2023)

10.7 Others Revenue Growth Rate (2013-2023)

11 Global Non-alcoholic Steatohepatitis Market Segment by Application

11.1 Global Non-alcoholic Steatohepatitis Revenue Market Share by Application (2013-2018)

11.2 Non-alcoholic Steatohepatitis Market Forecast by Application (2018-2023)

11.3 Pharma & CRO Industry Revenue Growth (2013-2018)

11.4 Hospitals Revenue Growth (2013-2018)

11.5 Diagnostic Labs Revenue Growth (2013-2018)

11.6 Academic Research Institutes Revenue Growth (2013-2018)

12 Global Non-alcoholic Steatohepatitis Market Size Forecast (2018-2023)

12.1 Global Non-alcoholic Steatohepatitis Market Size Forecast (2018-2023)

12.2 Global Non-alcoholic Steatohepatitis Market Forecast by Regions (2018-2023)

12.3 North America Non-alcoholic Steatohepatitis Revenue Market Forecast (2018-2023)

12.4 Europe Non-alcoholic Steatohepatitis Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Non-alcoholic Steatohepatitis Revenue Market Forecast (2018-2023)

12.6 South America Non-alcoholic Steatohepatitis Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Non-alcoholic Steatohepatitis Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Non-alcoholic Steatohepatitis Picture

Table Product Specifications of Non-alcoholic Steatohepatitis

Table Global Non-alcoholic Steatohepatitis and Revenue (Million U

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery